Loading
Life sciences · Interventional Study
ClinicalTrials.gov · October 2, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT02243748). This is a study registration, not published results. Lead sponsor: City of Hope Medical Center. Recruitment status: COMPLETED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 361 participants (ACTUAL). Conditions: Caregiver, Psychological Impact of Cancer and Its Treatment, Recurrent Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer. Interventions: OTHER: Palliative Therapy; OTHER: quality-of-life assessment; OTHER: questionnaire administration. Primary outcome measures: Impact of the PCI on symptom control as compared to the usual care group , Up to 3 months; Impact of the PCI on patient QOL as compared to the usual care group , Up to 3 months; Impact of the PCI on psychological distress as compared to the usual care group , Up to 3 months; Impact of the PCI on caregiver burden as compared to the usual care group , Up to 3 months; Impact of the PCI on caregiver distress as compared to the usual care group , Up to 3 months; Impact of the PCI on caregiver skills preparation as compared to the usual care group , Up to 3 months; Impact of the PCI on caregiver QOL as compared to the usual care group , Up to 3 months; Effects of the PCI on resource utilization as compared to the usual care group , Up to 3 months. Brief summary: This clinical trial studies a palliative care intervention in improving symptom control and quality of life in patients with stage II-IV non-small cell lung cancer and their family caregivers. Palliative care programs can provide patients and their caregivers with information on how to manage their symptoms, maintain health and well-being, and access supportive care services. An interdisciplinary palliative care model may effectively link lung cancer patients to the appropriate supportive care services in a timely fashion.